Med Tech Market Reports


MedTech Business intelligence
supplied through Piribo and GlobalData

Deal and alliances

Life Science Companies' Deals and Alliances Research, Intelligence and Forecasts

These reports cover business development issues in the biotechnology, life sciences and phamaceutical industry, including alliances, licensing and partnerships, deal news and co-marketing agreements in Europe, North America and Asia.

Title Publication Date Price
(approx)
Abbott Laboratories — Deals & Alliances Report January 2010 £385
AstraZeneca plc — Deals & Alliances Report January 2010 £385
Medtronic, Inc. — Deals & Alliances Report January 2010 £385
Monsanto Co. — Deals & Alliances Report January 2010 £385
Medicines Co. — Deals & Alliances Report January 2010 £385
Johnson & Johnson — Deals & Alliances Report January 2010 £385
Novartis AG — Deals & Alliances Report January 2010 £385
Eli Lilly & Co. — Deals & Alliances Report January 2010 £385
Smith & Nephew plc — Deals & Alliances Report January 2010 £385
Medicis Pharmaceutical Corp. — Deals & Alliances Report January 2010 £385
Mediware Information Systems Inc. — Deals & Alliances Report January 2010 £385
MediciNova Inc. — Deals & Alliances Report January 2010 £385
Medarex, Inc. — Deals & Alliances Report January 2010 £385
Masimo Corporation — Deals & Alliances Report January 2010 £385
Maxygen, Inc. — Deals & Alliances Report January 2010 £385
McKesson Corp. — Deals & Alliances Report January 2010 £385
Merck & Co. Inc. — Deals & Alliances Report January 2010 £385
Misonix Inc. — Deals & Alliances Report January 2010 £385
MultiCell Technologies, Inc. — Deals & Alliances Report January 2010 £385
Millipore Corp. — Deals & Alliances Report January 2010 £385
Micromet, Inc. — Deals & Alliances Report January 2010 £385
Merge Healthcare Incorporated. — Deals & Alliances Report January 2010 £385
Merit Medical Systems Inc. — Deals & Alliances Report January 2010 £385
Martek Biosciences Corp. — Deals & Alliances Report January 2010 £385
MZT Holdings, Inc. — Deals & Alliances Report January 2010 £385
Keryx Biopharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
King Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Jazz Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Isis Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
InterMune Inc. — Deals & Alliances Report January 2010 £385
International Stem Cell Corporation — Deals & Alliances Report January 2010 £385
Intuitive Surgical, Inc. — Deals & Alliances Report January 2010 £385
Laboratory Corp. of America Holdings — Deals & Alliances Report January 2010 £385
Lannett Co. Inc. — Deals & Alliances Report January 2010 £385
Luminex Corporation — Deals & Alliances Report January 2010 £385
MDRNA, Inc. — Deals & Alliances Report January 2010 £385
MDS, Inc. — Deals & Alliances Report January 2010 £385
Ligand Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Life Technologies Corporation — Deals & Alliances Report January 2010 £385
Lescarden Inc. — Deals & Alliances Report January 2010 £385
Lexicon Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Mylan, Inc. — Deals & Alliances Report January 2010 £385
Myriad Genetics Inc. — Deals & Alliances Report January 2010 £385
Orthofix International NV — Deals & Alliances Report January 2010 £385
Thermogenesis Corp. — Deals & Alliances Report January 2010 £385
ACADIA Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Orchid Cellmark Inc. — Deals & Alliances Report January 2010 £385
Opko Health, Inc. — Deals & Alliances Report January 2010 £385
Omnicell Inc. — Deals & Alliances Report January 2010 £385
Oncothyreon Inc — Deals & Alliances Report January 2010 £385
Onyx Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
AMAG Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
ATS Medical Inc. — Deals & Alliances Report January 2010 £385
Abraxis BioScience, Inc. — Deals & Alliances Report January 2010 £385
Abviva, Inc — Deals & Alliances Report January 2010 £385
Accelrys Inc. — Deals & Alliances Report January 2010 £385
Abaxis Inc. — Deals & Alliances Report January 2010 £385
AVI Biopharma, Inc. — Deals & Alliances Report January 2010 £385
Aastrom Biosciences, Inc. — Deals & Alliances Report January 2010 £385
Omnicare Inc. — Deals & Alliances Report January 2010 £385
OmniComm Systems Inc. — Deals & Alliances Report January 2010 £385
NeoPharm, Inc. — Deals & Alliances Report January 2010 £385
Neoprobe Corp. — Deals & Alliances Report January 2010 £385
Neose Technologies Inc. — Deals & Alliances Report January 2010 £385
Nektar Therapeutics — Deals & Alliances Report January 2010 £385
Nanogen, Inc. — Deals & Alliances Report January 2010 £385
NPS Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Nabi Biopharmaceuticals — Deals & Alliances Report January 2010 £385
Neurocrine Biosciences Inc. — Deals & Alliances Report January 2010 £385
Neurogen Corp. — Deals & Alliances Report January 2010 £385
Novavax, Inc. — Deals & Alliances Report January 2010 £385
Nutrition 21 Inc. — Deals & Alliances Report January 2010 £385
Nymox Pharmaceutical Corporation — Deals & Alliances Report January 2010 £385
Novadel Pharma Inc. — Deals & Alliances Report January 2010 £385
NexMed Inc. — Deals & Alliances Report January 2010 £385
North American Scientific Inc. — Deals & Alliances Report January 2010 £385
Insmed Incorporated — Deals & Alliances Report January 2010 £385
Insite Vision Inc. — Deals & Alliances Report January 2010 £385
Procter & Gamble Co. — Deals & Alliances Report January 2010 £385
Progenics Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
QLT Inc. — Deals & Alliances Report January 2010 £385
Pro-Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Poniard Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Pharmaceutical Product Development Inc. — Deals & Alliances Report January 2010 £385
Phase Forward Inc. — Deals & Alliances Report January 2010 £385
PhotoMedex, Inc. — Deals & Alliances Report January 2010 £385
Qiagen NV — Deals & Alliances Report January 2010 £385
Quadramed Corp. — Deals & Alliances Report January 2010 £385
Repros Therapeutics Inc. — Deals & Alliances Report January 2010 £385
ResMed Inc. — Deals & Alliances Report January 2010 £385
Rexahn Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Repligen Corporation — Deals & Alliances Report January 2010 £385
Regeneron Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Questcor Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Quidel Corp. — Deals & Alliances Report January 2010 £385
Pfizer Inc. — Deals & Alliances Report January 2010 £385
Perrigo Co. — Deals & Alliances Report January 2010 £385
Oxigene Inc. — Deals & Alliances Report January 2010 £385
PDL BioPharma, Inc. — Deals & Alliances Report January 2010 £385
Pacific Biometrics Inc. — Deals & Alliances Report January 2010 £385
Osiris Therapeutics, Inc. — Deals & Alliances Report January 2010 £385
OraSure Technologies Inc. — Deals & Alliances Report January 2010 £385
Ardea Biosciences, Inc. — Deals & Alliances Report January 2010 £385
OSI Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
OSI Systems, Inc. — Deals & Alliances Report January 2010 £385
Palatin Technologies Inc. — Deals & Alliances Report January 2010 £385
Pall Corp. — Deals & Alliances Report January 2010 £385
Penwest Pharmaceuticals Co. — Deals & Alliances Report January 2010 £385
Peregrine Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
PerkinElmer Inc. — Deals & Alliances Report January 2010 £385
Parexel International Corp. — Deals & Alliances Report January 2010 £385
Par Pharmaceutical Companies Inc. — Deals & Alliances Report January 2010 £385
Palomar Medical Technologies Inc. — Deals & Alliances Report January 2010 £385
Panacos Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Rigel Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Rochester Medical Corp. — Deals & Alliances Report January 2010 £385
Symyx Technologies Inc. — Deals & Alliances Report January 2010 £385
XTL Biopharmaceuticals Ltd. — Deals & Alliances Report January 2010 £385
ZOLL Medical Corp. — Deals & Alliances Report January 2010 £385
SurModics Inc. — Deals & Alliances Report January 2010 £385
Sunesis Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Spectrum Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Stem Cell Innovations, Inc. — Deals & Alliances Report January 2010 £385
Strategic Diagnostics Inc. — Deals & Alliances Report January 2010 £385
Zila, Inc. — Deals & Alliances Report January 2010 £385
Zimmer Holdings Inc. — Deals & Alliances Report January 2010 £385
IR Biosciences Holdings Inc. — Deals & Alliances Report January 2010 £385
IRIS International Inc. — Deals & Alliances Report January 2010 £385
ISTA Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
3M Co. — Deals & Alliances Report January 2010 £385
ZymoGenetics, Inc. — Deals & Alliances Report January 2010 £385
pSivida Corp. — Deals & Alliances Report January 2010 £385
SonoSite Inc. — Deals & Alliances Report January 2010 £385
Sangamo Biosciences Inc. — Deals & Alliances Report January 2010 £385
Santarus Inc. — Deals & Alliances Report January 2010 £385
SciClone Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Samaritan Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Salix Pharmaceuticals Ltd. — Deals & Alliances Report January 2010 £385
Rosetta Genomics, Ltd. — Deals & Alliances Report January 2010 £385
SIGA Technologies Inc. — Deals & Alliances Report January 2010 £385
Seattle Genetics Inc. — Deals & Alliances Report January 2010 £385
Senesco Technologies Inc. — Deals & Alliances Report January 2010 £385
Sigma-Aldrich Corporation — Deals & Alliances Report January 2010 £385
Simulations Plus Inc. — Deals & Alliances Report January 2010 £385
Skinvisible Inc. — Deals & Alliances Report January 2010 £385
Shire Limited — Deals & Alliances Report January 2010 £385
Sequenom Inc. — Deals & Alliances Report January 2010 £385
Senetek plc — Deals & Alliances Report January 2010 £385
Senomyx Inc. — Deals & Alliances Report January 2010 £385
Accentia Biopharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Inspire Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Cepheid — Deals & Alliances Report January 2010 £385
Cerner Corp. — Deals & Alliances Report January 2010 £385
Cerus Corporation — Deals & Alliances Report January 2010 £385
Cephalon Inc. — Deals & Alliances Report January 2010 £385
Celsion Corp. — Deals & Alliances Report January 2010 £385
Celgene Corporation — Deals & Alliances Report January 2010 £385
Cell Genesys, Inc. — Deals & Alliances Report January 2010 £385
Charles River Laboratories International Inc. — Deals & Alliances Report January 2010 £385
Clarient, Inc. — Deals & Alliances Report January 2010 £385
Compugen Ltd. — Deals & Alliances Report January 2010 £385
Corgenix Medical Corp. — Deals & Alliances Report January 2010 £385
Cornerstone Therapeutics Inc. — Deals & Alliances Report January 2010 £385
Commonwealth Biotechnologies Inc. — Deals & Alliances Report January 2010 £385
CombiMatrix Corporation — Deals & Alliances Report January 2010 £385
Clinical Data, Inc. — Deals & Alliances Report January 2010 £385
Columbia Laboratories Inc. — Deals & Alliances Report January 2010 £385
Celera Corporation — Deals & Alliances Report January 2010 £385
Cardinal Health, Inc. — Deals & Alliances Report January 2010 £385
Biomerica Inc. — Deals & Alliances Report January 2010 £385
Biomoda Inc. — Deals & Alliances Report January 2010 £385
Biovail Corporation — Deals & Alliances Report January 2010 £385
Biolase Technology, Inc. — Deals & Alliances Report January 2010 £385
Bioject Medical Technologies Inc. — Deals & Alliances Report January 2010 £385
Biogen Idec Inc. — Deals & Alliances Report January 2010 £385
Bioheart, Inc. — Deals & Alliances Report January 2010 £385
Boston Scientific Corporation — Deals & Alliances Report January 2010 £385
Bristol-Myers Squibb Co. — Deals & Alliances Report January 2010 £385
Cambrex Corp. — Deals & Alliances Report January 2010 £385
Caraco Pharmaceutical Laboratories Ltd. — Deals & Alliances Report January 2010 £385
Calypte Biomedical Corp. — Deals & Alliances Report January 2010 £385
Callisto Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Bruker Corporation — Deals & Alliances Report January 2010 £385
Caliper Life Sciences, Inc. — Deals & Alliances Report January 2010 £385
Covidien, Ltd. — Deals & Alliances Report January 2010 £385
Cubist Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Milestone Scientific Inc. — Deals & Alliances Report January 2010 £385
Nxstage Medical, Inc. — Deals & Alliances Report January 2010 £385
Oculus Innovative Sciences, Inc. — Deals & Alliances Report January 2010 £385
Manhattan Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Let's Talk Recovery, Inc. — Deals & Alliances Report January 2010 £385
Inovio Biomedical Corporation — Deals & Alliances Report January 2010 £385
Kensey Nash Corp. — Deals & Alliances Report January 2010 £385
Osteotech, Inc. — Deals & Alliances Report January 2010 £385
Pressure BioSciences, Inc. — Deals & Alliances Report January 2010 £385
Somanetics Corp. — Deals & Alliances Report January 2010 £385
Access Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Response Genetics, Inc — Deals & Alliances Report January 2010 £385
Raptor Pharmaceuticals Corp. — Deals & Alliances Report January 2010 £385
Pure Bioscience — Deals & Alliances Report January 2010 £385
Quick-Med Technologies Inc. — Deals & Alliances Report January 2010 £385
Impax Laboratories Inc. — Deals & Alliances Report January 2010 £385
Cryo-Cell International Inc. — Deals & Alliances Report January 2010 £385
Advaxis Inc. — Deals & Alliances Report January 2010 £385
Aethlon Medical Inc. — Deals & Alliances Report January 2010 £385
Radient Pharmaceuticals Corporation — Deals & Alliances Report January 2010 £385
Natus Medical Inc. — Deals & Alliances Report January 2010 £385
Immucor Inc. — Deals & Alliances Report January 2010 £385
CuraGen Corp. — Deals & Alliances Report January 2010 £385
Curis Inc. — Deals & Alliances Report January 2010 £385
AMICAS Inc. — Deals & Alliances Report January 2010 £385
AdvanSource Biomaterials Corporation — Deals & Alliances Report January 2010 £385
Ceragenix Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Cleveland Biolabs, Inc. — Deals & Alliances Report January 2010 £385
Celldex Therapeutics, Inc. — Deals & Alliances Report January 2010 £385
BioSphere Medical Inc. — Deals & Alliances Report January 2010 £385
BioClinica, Inc. — Deals & Alliances Report January 2010 £385
BioLife Solutions, Inc. — Deals & Alliances Report January 2010 £385
BioTime, Inc. — Deals & Alliances Report January 2010 £385
Sucampo Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Amarillo Biosciences Inc. — Deals & Alliances Report January 2010 £385
Adherex Technologies Inc. — Deals & Alliances Report January 2010 £385
Adeona Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Altus Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Adolor Corp. — Deals & Alliances Report January 2010 £385
Alseres Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Advanced Cell Technology Inc. — Deals & Alliances Report January 2010 £385
Acorda Therapeutics, Inc. — Deals & Alliances Report January 2010 £385
Achillion Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Amgen Inc. — Deals & Alliances Report January 2010 £385
Advanced Life Sciences Holdings, Inc. — Deals & Alliances Report January 2010 £385
Amerisourcebergen Corp. — Deals & Alliances Report January 2010 £385
American Medical Systems Holdings Inc. — Deals & Alliances Report January 2010 £385
Accuray Incorporated — Deals & Alliances Report January 2010 £385
Amarin Corporation plc — Deals & Alliances Report January 2010 £385
Alpharx Inc. — Deals & Alliances Report January 2010 £385
Alpha Innotech Corporation — Deals & Alliances Report January 2010 £385
Affymetrix Inc. — Deals & Alliances Report January 2010 £385
Air Products & Chemicals Inc. — Deals & Alliances Report January 2010 £385
Akorn Inc. — Deals & Alliances Report January 2010 £385
Aetna Inc. — Deals & Alliances Report January 2010 £385
Aeterna Zentaris Inc. — Deals & Alliances Report January 2010 £385
Advanced Plant Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Adventrx Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Albany Molecular Research Inc. — Deals & Alliances Report January 2010 £385
Alcon Inc. — Deals & Alliances Report January 2010 £385
Alliance Pharmaceutical Corp. — Deals & Alliances Report January 2010 £385
Alnylam Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Allergan Inc. — Deals & Alliances Report January 2010 £385
Alkermes, Inc. — Deals & Alliances Report January 2010 £385
Alexion Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Alfacell Corp. — Deals & Alliances Report January 2010 £385
Anadys Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Amylin Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Avitar Inc. — Deals & Alliances Report January 2010 £385
BELLUS Health Inc. — Deals & Alliances Report January 2010 £385
BMP Sunstone Corporation — Deals & Alliances Report January 2010 £385
Avigen Inc. — Deals & Alliances Report January 2010 £385
Averion International Corp. — Deals & Alliances Report January 2010 £385
Athersys, Inc. — Deals & Alliances Report January 2010 £385
Auxilium Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Avanir Pharmaceuticals — Deals & Alliances Report January 2010 £385
Baxter International Inc. — Deals & Alliances Report January 2010 £385
Beckman Coulter Inc. — Deals & Alliances Report January 2010 £385
BioElectronics Corporation — Deals & Alliances Report January 2010 £385
BioForce Nanosciences Holdings, Inc. — Deals & Alliances Report January 2010 £385
BioMarin Pharmaceutical Inc. — Deals & Alliances Report January 2010 £385
BioSante Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
BioDelivery Sciences International Inc. — Deals & Alliances Report January 2010 £385
Bio-Reference Laboratories Inc. — Deals & Alliances Report January 2010 £385
BioCryst Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Aspect Medical Systems, Inc. — Deals & Alliances Report January 2010 £385
Antares Pharma Inc. — Deals & Alliances Report January 2010 £385
Analogic Corporation — Deals & Alliances Report January 2010 £385
Anika Therapeutics Inc. — Deals & Alliances Report January 2010 £385
Angiotech Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Anesiva, Inc. — Deals & Alliances Report January 2010 £385
AngioDynamics Inc. — Deals & Alliances Report January 2010 £385
ArQule Inc. — Deals & Alliances Report January 2010 £385
Antigenics Inc. — Deals & Alliances Report January 2010 £385
Ariad Pharmaceuticals Inc. — Deals & Alliances Report January 2010 £385
Array BioPharma, Inc. — Deals & Alliances Report January 2010 £385
Arrowhead Research Corp. — Deals & Alliances Report January 2010 £385
Arena Pharmaceuticals, Inc. — Deals & Alliances Report January 2010 £385
Aradigm Corp. — Deals & Alliances Report January 2010 £385
ArthroCare Corporation — Deals & Alliances Report January 2010 £385

To top